# PRospective Study for the TrEatment of Atherosclerotic Lesions in the Superficial Femoral and/or Popliteal Arteries Using the Serranator DevicE

> **NCT03001700** · NA · COMPLETED · sponsor: **Cagent Vascular LLC** · enrollment: 25 (actual)

## Conditions studied

- Peripheral Arterial Disease

## Interventions

- **DEVICE:** Serranator™ Alto PTA Serration Balloon Catheter

## Key facts

- **NCT ID:** NCT03001700
- **Lead sponsor:** Cagent Vascular LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-01
- **Primary completion:** 2017-05-31
- **Final completion:** 2017-12-31
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2018-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03001700

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03001700, "PRospective Study for the TrEatment of Atherosclerotic Lesions in the Superficial Femoral and/or Popliteal Arteries Using the Serranator DevicE". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03001700. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*